ABSCINT Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 6

ABSCINT General Information

Description

Developer of an in vivo molecular imaging diagnostics platform designed to improve patient stratification and treatment monitoring. The company offers PET-based molecular imaging diagnostics, including an anti-HER receptor tracer for whole-body assessment of receptor expression and tumor heterogeneity, enabling oncologists and cancer care teams to more accurately stratify patients and monitor treatment response.

Contact Information

Website
www.abscint.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • Boulevard Patience et Beaujonc 3
  • 4000 Liège
  • Belgium
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • Boulevard Patience et Beaujonc 3
  • 4000 Liège
  • Belgium

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ABSCINT Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ABSCINT‘s full profile, request access.

Request a free trial

ABSCINT Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an in vivo molecular imaging diagnostics platform designed to improve patient stratification and treatment
Diagnostic Equipment
Liège, Belgium
10 As of 2026

Solna, Sweden
 

Calabasas, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ABSCINT Competitors (2)

One of ABSCINT’s 2 competitors is Affibody, a Venture Capital-Backed company based in Solna, Sweden.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Affibody Venture Capital-Backed Solna, Sweden
ImaginAb Venture Capital-Backed Calabasas, CA
You’re viewing 2 of 2 competitors. Get the full list »

ABSCINT Patents

ABSCINT Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024366659-A1 Image guided biopsy of her2 positive lesions Pending 26-Oct-2023
EP-4798258-A1 Image guided biopsy of her2 positive lesions Pending 26-Oct-2023
WO-2025088085-A1 Image guided biopsy of her2 positive lesions Inactive 26-Oct-2023
JP-2026538079-A Image-guided biopsy of her2-positive lesions Pending 26-Oct-2023

ABSCINT Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ABSCINT Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ABSCINT‘s full profile, request access.

Request a free trial

ABSCINT FAQs

  • When was ABSCINT founded?

    ABSCINT was founded in 2020.

  • Where is ABSCINT headquartered?

    ABSCINT is headquartered in Liège, Belgium.

  • What is the size of ABSCINT?

    ABSCINT has 10 total employees.

  • What industry is ABSCINT in?

    ABSCINT’s primary industry is Diagnostic Equipment.

  • Is ABSCINT a private or public company?

    ABSCINT is a Private company.

  • What is ABSCINT’s current revenue?

    The current revenue for ABSCINT is .

  • How much funding has ABSCINT raised over time?

    ABSCINT has raised $3.93M.

  • Who are ABSCINT’s investors?

    Bruzz - Vlaams-Brusselse Media, Kazoku, Lifetech Brussels, Noshaq, and Qbic Fund are 5 of 10 investors who have invested in ABSCINT.

  • Who are ABSCINT’s competitors?

    Affibody and ImaginAb are competitors of ABSCINT.

  • When was ABSCINT acquired?

    ABSCINT was acquired on 10-Aug-2026.

  • Who acquired ABSCINT?

    ABSCINT was acquired by Curium Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process